Catalog No.S1304 Synonyms: BDH1298, SC10363
Molecular Weight(MW): 384.51
Megestrol acetate is a synthetic progestogen, used to treat breast cancer and loss of appetite.
2 Customer Reviews
HEC-1A cells were treated with pterostilbene (75 μM), megestrol acetate (75 μM) or the combination for 24 h. Whole cell lysates were collected and measured for the change of cell cycle and apoptosis pathways by Western blot. Results are representative of 3 or more preparations.
Sci Rep, 2017, 7(1):12754. Megestrol Acetate purchased from Selleck.
Kaempferol and ER/PR inhibitor suppress the migration and Rho activity of MCF-7 cells. Notes: (A) MCF-7 ER+/PR+ breast cancer cells were allowed to migrate in response to 20 μmol/L kaempferol and/or 0.1 nmol/L AZD9496 (ER inhibitor) and 200 μmol/L megestrol acetate (PR inhibitor) for 6 h. Results are presented as mean ± SD of 5 independent experiments. (B, C) MCF-7 cells were incubated with 20 μmol/L kaempferol and/or 0.1 nmol/L AZD9496 and 200 μmol/L MA for 1 h, and then subjected to the RhoA (B) and Rac1 (C) activity assays. The relative levels of Rho activity were normalized to the average value of controls. Results are presented as mean ± SD of 3 independent experiments. Abbreviations: AZD, AZD9496; Ctrl, control; ER, estrogen receptor; MA, megestrol acetate; ns, no significance; PR, progesterone receptor.
Onco Targets Ther, 2017, 10:4809-4819. Megestrol Acetate purchased from Selleck.
Purity & Quality Control
Choose Selective Estrogen/progestogen Receptor Inhibitors
|Description||Megestrol acetate is a synthetic progestogen, used to treat breast cancer and loss of appetite.|
Megestrol acetate inhibits the expression of cytoplasmic aromatase through nuclear C/EBPβ in reperfusion injury-induced ischemic rat hippocampus.  Megestrol acetate significantly increases the proliferation, migration, and adipogenic differentiation of adipose-derived stem cells (ASCs) in a dose-dependent manner. Megestrol acetate also upregulates genes downstream of glucocorticoid receptor (GR) in ASCs. 
|In vivo||Megestrol acetate significantly decreases the circulating concentrations of estradiol (E2) and testosterone (T) in female fish or 11-ketotestosterone (11-KT) in male fish. Megestrol acetate exposure significantly downregulates the transcription of certain genes along the hypothalamic-pituitary-gonadal (HPG) axis.  Megestrol acetate produces a progressive deterioration in glucose tolerance, with a significant increase in mean fasting plasma glucose concentrations and decrease in mean plasma glucose clearance rates after 6 months and 12 months of treatment in cats. Megestrol acetate also produces a progressive decrease in both resting plasma cortisol concentrations and cortisol concentrations after ACTH stimulation in cats.  Megestrol acetate (50 mg/kg/day) for 9 days significantly increases food and water intake compared with untreated controls. Megestrol acetate (50 mg/kg/day) significantly (90-140%) increases in neuropeptide Y concentrations in the arcuate nucleus (where neuropeptide Y is synthesized), in the lateral hypothalamic area (through which arcuate neurones project) and in the medial preoptic area, ventromedial nucleus and dorsomedial nucleus in rats. |
-  Kelicen Ugur P, et al. Eur J Pharmacol, 2011, 654(3), 217-225.
-  Sung JH, et al. Stem燙ells燭ransl Med,?015, 4(7), 789-799.
-  Han J, et al. Aquat Toxicol,?014, 150, 66-72.
|In vitro||DMSO||33 mg/mL (85.82 mM)|
|Ethanol||15 mg/mL (39.01 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT03024580||Not yet recruiting||Breast Neoplasm||Instituto Nacional de Cancer, Brazil|Cancer Research UK Cambridge Institute||March 2017||Phase 2|
|NCT02619266||Recruiting||Anorexia|Cancer Cachexia||Xinqiao Hospital of Chongqing|Chengdu University of Traditional Chinese Medicine||December 2015||Phase 2|Phase 3|
|NCT02595723||Completed||Cognitive Impairment||University of Texas Southwestern Medical Center|The Rogosin Institute||July 2015||Early Phase 1|
|NCT02980653||Recruiting||Head and Neck Cancer||TTY Biopharm|Chang Gung Memorial Hospital||May 2015||Phase 2|
|NCT02269670||Active, not recruiting||Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer||Emory University|Novartis||November 2014||Phase 2|
|NCT01943058||Withdrawn||Atypical Endometrial Hyperplasia|Endometrial Adenocarcinoma|Recurrent Endometrial Carcinoma|Stage IA Endometrial Carcinoma|Stage IB Endometrial Carcinoma|Stage II Endometrial Carcinoma|Stage IIIA Endometrial Carcinoma|Stage IIIB Endometrial Carcinoma|Stage IIIC Endometrial Carcinoma|Stage IVA Endometrial Carcinoma|Stage IVB Endometrial Carcinoma||University of Southern California|National Cancer Institute (NCI)||March 2014||Phase 2|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.